Glenmark settles with Nycomed, to launch Cutivate generic in US next year
This article was originally published in Scrip
Executive Summary
Glenmark Generics expects to launch its generic version of Nycomed's Cutivate lotion (fluticasone propionate 0.05%) in the US early next year, following a settlement and licence pact with the originator firm.